Quarterly Consolidated Statement Of Cash Flows

STELLA PHARMA CORPORATION - Filing #7350910

Concept 2023-04-01 to
2023-12-31
2022-04-01 to
2022-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-467,422,000 JPY
-480,498,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.